Altered endocannabinoid-dynamics in craniopharyngioma patients and their association with HPA-axis disturbances

in European Journal of Endocrinology
View More View Less
  • 1 Medizinische Klinik and Poliklinik IV, Klinikum der Universität München, LMU München, Munich, Germany
  • | 2 Research Group Clinical Neuroendocrinology, Max Planck Institute of Psychiatry, Munich, Germany
  • | 3 Department of Psychiatry and Psychotherapy, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • | 4 Human Behavior Laboratory, Institute for Sex Research and Forensic Psychiatry, University Medical Center Hamburg-Eppendorf, Germany
  • | 5 Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
  • | 6 Medicover Neuroendocrinology, Munich, Germany
  • | 7 Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany

Correspondence should be addressed to M K Auer; Email: matthias.auer@med.uni-muenchen.de
Restricted access

Objective

Patients with craniopharyngioma (CP) frequently suffer from morbid obesity. Endocannabinoids (ECs) are involved in weight gain and rewarding behavior but have not been investigated in this context.

Design

Cross-sectional single-center study.

Methods

Eighteen patients with CP and 16 age- and sex-matched controls were included. Differences in endocannabinoids (2-arachidonoylglycerol (2-AG) and N-arachidonoylethanolamine (AEA)) and endocannabinoid-like molecules (oleoyl ethanolamide (OEA), palmitoylethanolamide (PEA), and arachidonic acid (AA) were measured at baseline and following endurance exercise. We further explored ECs-dynamics in relation to markers of HPA-axis activity (ACTH, cortisol, copeptin) and hypothalamic damage.

Results

Under resting conditions, independent of differences in BMI, 2-AG levels were more than twice as high in CP patients compared to controls. In contrast, 2-AG and OEA level increased in response to exercise in controls but not in CP patients, while AEA levels decreased in controls. As expected, exercise increased ACTH and copeptin levels in controls only. In a mixed model analysis across time and group, HPA measures did not provide additional information for explaining differences in 2-AG levels. However, AEA levels were negatively influenced by ACTH and copeptin levels, while OEA levels were negatively predicted by copeptin levels only. There were no significant differences in endocannabinoids depending on hypothalamic involvement.

Conclusion

Patients with CP show signs of a dysregulated endocannabinoid system under resting conditions as well as following exercise in comparison to healthy controls. Increased 2-AG levels under resting conditions and the missing response to physical activity could contribute to the metabolic phenotype of CP patients.

 

     European Society of Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 822 822 219
Full Text Views 81 81 7
PDF Downloads 87 87 10
  • 1

    Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. Journal of Neurosurgery 1998 89 547551. (https://doi.org/10.3171/jns.1998.89.4.0547).

    • Search Google Scholar
    • Export Citation
  • 2

    Müller HL Craniopharyngioma. Endocrine Reviews 2014 35 513543. (https://doi.org/10.1210/er.2013-1115)

  • 3

    Karavitaki N, Wass JA. Craniopharyngiomas. Endocrinology and Metabolism Clinics of North America 2008 37 1731 93. (https://doi.org/10.1016/j.ecl.2007.10.012)

    • Search Google Scholar
    • Export Citation
  • 4

    Lustig RH Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment. Frontiers in Endocrinology 2011 2 60. (https://doi.org/10.3389/fendo.2011.00060)

    • Search Google Scholar
    • Export Citation
  • 5

    Müller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Pohl F, Sörensen N & Calaminus G et al. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. European Journal of Endocrinology 2011 165 1724. (https://doi.org/10.1530/EJE-11-0158)

    • Search Google Scholar
    • Export Citation
  • 6

    Jung HW, Kim HY, Kim JY, Cheon JE, Kim IO, Kim SK, Shin CH, Yang SW, Lee YA. Autonomic dysfunction is associated with increased cardiometabolic risk in patients with childhood-onset craniopharyngioma. Hormone and Metabolic Research 2020 52 500508. (https://doi.org/10.1055/a-1169-0307)

    • Search Google Scholar
    • Export Citation
  • 7

    Roth CL, Hunneman DH, Gebhardt U, Stoffel-Wagner B, Reinehr T, Müller HL. Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma. Pediatric Research 2007 61 496501. (https://doi.org/10.1203/pdr.0b013e3180332cd6)

    • Search Google Scholar
    • Export Citation
  • 8

    Holmer H, Pozarek G, Wirfält E, Popovic V, Ekman B, Björk J, Erfurth EM. Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma. Journal of Clinical Endocrinology and Metabolism 2010 95 53955402. (https://doi.org/10.1210/jc.2010-0993)

    • Search Google Scholar
    • Export Citation
  • 9

    Shaikh MG, Grundy RG, Kirk JMW. Reductions in basal metabolic rate and physical activity contribute to hypothalamic obesity. Journal of Clinical Endocrinology and Metabolism 2008 93 25882593. (https://doi.org/10.1210/jc.2007-2672)

    • Search Google Scholar
    • Export Citation
  • 10

    Roemmler-Zehrer J, Geigenberger V, Störmann S, Ising M, Pfister H, Sievers C, Stalla GK, Schopohl J. Specific behaviour, mood and personality traits may contribute to obesity in patients with craniopharyngioma. Clinical Endocrinology 2015 82 106114. (https://doi.org/10.1111/cen.12523)

    • Search Google Scholar
    • Export Citation
  • 11

    Harz KJ, Müller HL, Waldeck E, Pudel V, Roth C. Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. Journal of Clinical Endocrinology and Metabolism 2003 88 52275231. (https://doi.org/10.1210/jc.2002-021797)

    • Search Google Scholar
    • Export Citation
  • 12

    Kirkham TC, Williams CM, Fezza F, Marzo VD. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. British Journal of Pharmacology 2002 136 550557. (https://doi.org/10.1038/sj.bjp.0704767)

    • Search Google Scholar
    • Export Citation
  • 13

    Matias I, Di Marzo V. Endocannabinoids and the control of energy balance. Trends in Endocrinology and Metabolism 2007 18 2737. (https://doi.org/10.1016/j.tem.2006.11.006)

    • Search Google Scholar
    • Export Citation
  • 14

    Silvestri C, Di Marzo V. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metabolism 2013 17 475490. (https://doi.org/10.1016/j.cmet.2013.03.001)

    • Search Google Scholar
    • Export Citation
  • 15

    Bellocchio L, Soria-Gómez E, Quarta C, Metna-Laurent M, Cardinal P, Binder E, Cannich A, Delamarre A, Häring M & Martín-Fontecha M et al. Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade. PNAS 2013 110 47864791. (https://doi.org/10.1073/pnas.1218573110)

    • Search Google Scholar
    • Export Citation
  • 16

    Miralpeix C, Fosch A, Casas J, Baena M, Herrero L, Serra D, Rodríguez-Rodríguez R, Casals N. Hypothalamic endocannabinoids inversely correlate with the development of diet-induced obesity in male and female mice. Journal of Lipid Research 2019 60 12601269. (https://doi.org/10.1194/jlr.M092742)

    • Search Google Scholar
    • Export Citation
  • 17

    Fuss J, Bindila L, Wiedemann K, Auer MK, Briken P, Biedermann SV. Masturbation to orgasm stimulates the release of the endocannabinoid 2-arachidonoylglycerol in humans. Journal of Sexual Medicine 2017 14 13721379. (https://doi.org/10.1016/j.jsxm.2017.09.016)

    • Search Google Scholar
    • Export Citation
  • 18

    Fuss J, Steinle J, Bindila L, Auer MK, Kirchherr H, Lutz B, Gass P. A runner's high depends on cannabinoid receptors in mice. PNAS 2015 112 1310513108. (https://doi.org/10.1073/pnas.1514996112)

    • Search Google Scholar
    • Export Citation
  • 19

    Siebers M, Biedermann SV, Bindila L, Lutz B, Fuss J. Exercise-induced euphoria and anxiolysis do not depend on endogenous opioids in humans. Psychoneuroendocrinology 2021 126 105173. (https://doi.org/10.1016/j.psyneuen.2021.105173)

    • Search Google Scholar
    • Export Citation
  • 20

    Heyman E, Gamelin FX, Goekint M, Piscitelli F, Roelands B, Leclair E, Di Marzo V, Meeusen R. Intense exercise increases circulating endocannabinoid and BDNF levels in humans—possible implications for reward and depression. Psychoneuroendocrinology 2012 37 844851. (https://doi.org/10.1016/j.psyneuen.2011.09.017)

    • Search Google Scholar
    • Export Citation
  • 21

    De Petrocellis L, Cascio MG, Di Marzo V. The endocannabinoid system: a general view and latest additions. British Journal of Pharmacology 2004 141 765774. (https://doi.org/10.1038/sj.bjp.0705666)

    • Search Google Scholar
    • Export Citation
  • 22

    Quarta C, Bellocchio L, Mancini G, Mazza R, Cervino C, Braulke LJ, Fekete C, Latorre R, Nanni C & Bucci M et al. Bucci M. CB1 signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. Cell Metabolism 2010 11 273285. (https://doi.org/10.1016/j.cmet.2010.02.015)

    • Search Google Scholar
    • Export Citation
  • 23

    Mølhøj S, Hansen HS, Schweiger M, Zimmermann R, Johansen T, Malmlöf K. Effect of the cannabinoid receptor-1 antagonist rimonabant on lipolysis in rats. European Journal of Pharmacology 2010 646 3845. (https://doi.org/10.1016/j.ejphar.2010.08.006)

    • Search Google Scholar
    • Export Citation
  • 24

    van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rössner S. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005 365 13891397. (https://doi.org/10.1016/S0140-6736(0566374-X)

    • Search Google Scholar
    • Export Citation
  • 25

    Guzmán M, Lo Verme J, Fu J, Oveisi F, Blázquez C, Piomelli D. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). Journal of Biological Chemistry 2004 279 2784927854. (https://doi.org/10.1074/jbc.M404087200)

    • Search Google Scholar
    • Export Citation
  • 26

    Fanelli F, Mezzullo M, Repaci A, Belluomo I, Ibarra Gasparini D, Di Dalmazi G, Mastroroberto M, Vicennati V, Gambineri A & Morselli-Labate AM et al. Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism. Molecular Metabolism 2018 14 8294. (https://doi.org/10.1016/j.molmet.2018.06.002)

    • Search Google Scholar
    • Export Citation
  • 27

    Engeli S, Böhnke J, Feldpausch M, Gorzelniak K, Janke J, Bátkai S, Pacher P, Harvey-White J, Luft FC & Sharma AM et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes 2005 54 28382843. (https://doi.org/10.2337/diabetes.54.10.2838)

    • Search Google Scholar
    • Export Citation
  • 28

    Cote M, Matias I, Lemieux I, Petrosino S, Almeras N, Despres JP, Di Marzo V. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. International Journal of Obesity 2007 31 692699. (https://doi.org/10.1038/sj.ijo.0803539)

    • Search Google Scholar
    • Export Citation
  • 29

    Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 2004 145 54315438. (https://doi.org/10.1210/en.2004-0638)

    • Search Google Scholar
    • Export Citation
  • 30

    Hill MN, Miller GE, Carrier EJ, Gorzalka BB, Hillard CJ. Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology 2009 34 12571262. (https://doi.org/10.1016/j.psyneuen.2009.03.013)

    • Search Google Scholar
    • Export Citation
  • 31

    Hillard CJ Circulating endocannabinoids: From whence do they come and where are they going? Neuropsychopharmacology 2018 43 155172. (https://doi.org/10.1038/npp.2017.130)

    • Search Google Scholar
    • Export Citation
  • 32

    Gebert D, Auer MK, Stieg MR, Freitag MT, Lahne M, Fuss J, Schilbach K, Schopohl J, Stalla GK, Kopczak A. De-masking oxytocin-deficiency in craniopharyngioma and assessing its link with affective function. Psychoneuroendocrinology 2018 88 6169. (https://doi.org/10.1016/j.psyneuen.2017.11.006)

    • Search Google Scholar
    • Export Citation
  • 33

    Ziegler CG, Mohn C, Lamounier-Zepter V, Rettori V, Bornstein SR, Krug AW, Ehrhart-Bornstein M. Expression and function of endocannabinoid receptors in the human adrenal cortex. Hormone and Metabolic Research 2010 42 8892. (https://doi.org/10.1055/s-0029-1241860)

    • Search Google Scholar
    • Export Citation
  • 34

    Jung KM, Clapper JR, Fu J, D’Agostino G, Guijarro A, Thongkham D, Avanesian A, Astarita G, DiPatrizio NV & Frontini A et al. 2-arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism. Cell Metabolism 2012 15 299310. (https://doi.org/10.1016/j.cmet.2012.01.021)

    • Search Google Scholar
    • Export Citation
  • 35

    Argueta DA, DiPatrizio NV. Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity. Physiology and Behavior 2017 171 3239. (https://doi.org/10.1016/j.physbeh.2016.12.044)

    • Search Google Scholar
    • Export Citation
  • 36

    Coutant R, Maurey H, Rouleau S, Mathieu E, Mercier P, Limal JM & Le Bouil A Defect in epinephrine production in children with craniopharyngioma: functional or organic origin? Journal of Clinical Endocrinology and Metabolism 2003 88 59695975. (https://doi.org/10.1210/jc.2003-030552)

    • Search Google Scholar
    • Export Citation
  • 37

    Müller HL, Gebhardt U, Faldum A, Warmuth-Metz M, Pietsch T, Pohl F, Calaminus G, Sörensen N & Kraniopharyngeom 2000 Study Committee. Xanthogranuloma, Rathke’s cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations. Journal of Clinical Endocrinology and Metabolism 2012 97 39353943. (https://doi.org/10.1210/jc.2012-2069).

    • Search Google Scholar
    • Export Citation
  • 38

    Raichlen DA, Foster AD, Seillier A, Giuffrida A, Gerdeman GL. Exercise-induced endocannabinoid signaling is modulated by intensity. European Journal of Applied Physiology 2013 113 869875. (https://doi.org/10.1007/s00421-012-2495-5)

    • Search Google Scholar
    • Export Citation
  • 39

    Cedernaes J, Fanelli F, Fazzini A, Pagotto U, Broman JE, Vogel H, Dickson SL, Schiöth HB, Benedict C. Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans. Psychoneuroendocrinology 2016 74 258268.. (https://doi.org/10.1016/j.psyneuen.2016.09.014)

    • Search Google Scholar
    • Export Citation
  • 40

    Gonthier MP, Hoareau L, Festy F, Matias I, Valenti M, Bès-Houtmann S, Rouch C, Robert-Da Silva C, Chesne S & Lefebvre d’Hellencourt C et al. Identification of endocannabinoids and related compounds in human fat cells. Obesity 2007 15 837845. (https://doi.org/10.1038/oby.2007.581)

    • Search Google Scholar
    • Export Citation
  • 41

    Simon V, Cota D. Mechanisms in endocrinology: endocannabinoids and metabolism: past, present and future. European Journal of Endocrinology 2017 176 R309R324. (https://doi.org/10.1530/EJE-16-1044).

    • Search Google Scholar
    • Export Citation
  • 42

    Yoshida R, Ohkuri T, Jyotaki M, Yasuo T, Horio N, Yasumatsu K, Sanematsu K, Shigemura N, Yamamoto T & Margolskee RF et al. Endocannabinoids selectively enhance sweet taste. PNAS 2010 107 935939. (https://doi.org/10.1073/pnas.0912048107)

    • Search Google Scholar
    • Export Citation
  • 43

    DiPatrizio NV, Igarashi M, Narayanaswami V, Murray C, Gancayco J, Russell A, Jung KM, Piomelli D. Fasting stimulates 2-AG biosynthesis in the small intestine: role of cholinergic pathways. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 2015 309 R805R813. (https://doi.org/10.1152/ajpregu.00239.2015).

    • Search Google Scholar
    • Export Citation
  • 44

    Roth C, Wilken B, Hanefeld F, Schröter W, Leonhardt U. Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. European Journal of Endocrinology 1998 138 8991. (https://doi.org/10.1530/eje.0.1380089)

    • Search Google Scholar
    • Export Citation
  • 45

    Laleh P, Yaser K, Alireza O. Oleoylethanolamide: A novel pharmaceutical agent in the management of obesity-an updated review. Journal of Cellular Physiology 2019 234 78937902. (https://doi.org/10.1002/jcp.27913)

    • Search Google Scholar
    • Export Citation
  • 46

    Fu J, Astarita G, Gaetani S, Kim J, Cravatt BF, Mackie K, Piomelli D. Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine. Journal of Biological Chemistry 2007 282 15181528. (https://doi.org/10.1074/jbc.M607809200)

    • Search Google Scholar
    • Export Citation
  • 47

    Fuss J, Claro L, Ising M, Biedermann SV, Wiedemann K, Stalla GK, Briken P, Auer MK. Does sex hormone treatment reverse the sex-dependent stress regulation? A longitudinal study on hypothalamus-pituitary-adrenal (HPA) axis activity in transgender individuals. Psychoneuroendocrinology 2019 104 228237. (https://doi.org/10.1016/j.psyneuen.2019.02.023)

    • Search Google Scholar
    • Export Citation
  • 48

    Drummond JB, Soares BS, Pedrosa W, Vieira ELM, Teixeira AL, Christ-Crain M, Ribeiro-Oliveira A Jr. Copeptin response to hypoglycemic stress is linked to prolactin activation in children. Pituitary 2020 23 681690. (https://doi.org/10.1007/s11102-020-01076-6)

    • Search Google Scholar
    • Export Citation
  • 49

    Gray JM, Wilson CD, Lee TT, Pittman QJ, Deussing JM, Hillard CJ, McEwen BS, Schulkin J, Karatsoreos IN & Patel S et al. Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function. Psychoneuroendocrinology 2016 66 151158. (https://doi.org/10.1016/j.psyneuen.2016.01.004)

    • Search Google Scholar
    • Export Citation
  • 50

    Hill MN, McLaughlin RJ, Morrish AC, Viau V, Floresco SB, Hillard CJ, Gorzalka BB. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic–pituitary–adrenal axis. Neuropsychopharmacology 2009 34 27332745. (https://doi.org/10.1038/npp.2009.114)

    • Search Google Scholar
    • Export Citation
  • 51

    Bassir Nia A, Bender R, Harpaz-Rotem I. Endocannabinoid system alterations in posttraumatic stress disorder: a review of developmental and accumulative effects of trauma. Chronic Stress 2019 3 2470547019864096. (https://doi.org/10.1177/2470547019864096)

    • Search Google Scholar
    • Export Citation
  • 52

    Jumpertz R, Guijarro A, Pratley RE, Piomelli D, Krakoff J. Central and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditure. Journal of Clinical Endocrinology and Metabolism 2011 96 787791. (https://doi.org/10.1210/jc.2010-2028)

    • Search Google Scholar
    • Export Citation
  • 53

    Pickering L, Jennum P, Gammeltoft S, Poulsgaard L, Feldt-Rasmussen U, Klose M. Sleep-wake and melatonin pattern in craniopharyngioma patients. European Journal of Endocrinology 2014 170 873884. (https://doi.org/10.1530/EJE-13-1025)

    • Search Google Scholar
    • Export Citation
  • 54

    Hanlon EC, Tasali E, Leproult R, Stuhr KL, Doncheck E, De Wit H, Hillard CJ, Van Cauter E. Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol. Journal of Clinical Endocrinology and Metabolism 2015 100 220226. (https://doi.org/10.1210/jc.2014-3455)

    • Search Google Scholar
    • Export Citation
  • 55

    Martinez-Barbera JP, Andoniadou CL. Biological behaviour of craniopharyngiomas. Neuroendocrinology 2020 110 797804. (https://doi.org/10.1159/000506904)

    • Search Google Scholar
    • Export Citation